TrademarkDir
EAI
LIVE

Serial Number

98120597

Owner

Delphi Diagnostics, Inc.

Attorney

Naira Simmons

First Use Date

Dec 3, 2023

Filing Date

Aug 7, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EAI Trademark

Serial Number: 98120597 • Registration: 8070034

EAI is a trademark filed by Delphi Diagnostics, Inc. on August 7, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Delphi Diagnostics, Inc. (10 trademarks)

PO Box 341449
Austin, TX 78734

Entity Type: 03

Trademark Details

Filing Date

August 7, 2023

Registration Date

December 16, 2025

First Use Anywhere

December 3, 2023

First Use in Commerce

December 3, 2023

Published for Opposition

October 22, 2024

Goods & Services

Clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for testing biopsy and other tissue samples for use in disease detection, namely, breast cancer; clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for breast cancer surveillance, namely, for measuring amounts of genomic and other biomarkers contacted with the reagent, such as estrogen receptor (ER), progesterone receptor (PR) associated biomarkers, and other suitable biomarkers for monitoring breast cancer occurrence, recurrence, response to various chemotherapies, hormone therapies, radiation therapies, or other suitable treatments

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 16, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 16, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 26, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 26, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 22, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 22, 2025 AITU
USE AMENDMENT FILED
Jun 3, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 3, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 3, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2024 CRFA
ASSIGNED TO LIE
Sep 12, 2024 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 23, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 20, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 20, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 20, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 11, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 12, 2024 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 6, 2023 NWOS
NEW APPLICATION ENTERED
Aug 10, 2023 NWAP

Related Trademarks

More from this Owner

ENDOCRINE ACTIVITY INDEX

ENDOCRINE ACTIVITY INDEX

ENDOCRINE ACTIVITY INDEX

ENDOCRINE ACTIVITY INDEX

RCB

RCB

RCB

RCB

RESIDUAL CANCER BURDEN

RESIDUAL CANCER BURDEN

DELPHI DIAGNOSTICS

DELPHI DIAGNOSTICS